Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.35B 3.82B 3.55B 3.27B 6.13B 421B 6.24B 42.48B 16.57B 205B 16.32B 15.97B 712B P/E 2026 *
11.1x
P/E 2027 * 9.98x
Enterprise Value 5.82B 5.12B 4.75B 4.37B 8.2B 563B 8.35B 56.84B 22.17B 275B 21.84B 21.37B 953B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.57x
Free-Float
63.57%
Yield 2026 *
4.08%
Yield 2027 * 4.34%
1 day-1.02%
1 week+0.13%
Current month+2.17%
1 month+2.51%
3 months+10.73%
6 months-0.06%
Current year+0.19%
1 week 1,512
Extreme 1512
1,597
1 month 1,483
Extreme 1483
1,762
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
2,046
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,703
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
6/1/26 Fiscal year

Director

72,763 0.0339%
6/1/26 Fiscal year

Executive/Senior Manager

20,982 0.0098%
6/1/26 Fiscal year

Executive/Senior Manager

52,640 0.0245%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%+0.13%-22.16%-23.87% 4.35B
+1.97%+1.43%+48.44%+156.66% 1,057B
+1.42%+3.72%+53.32%+52.34% 624B
+1.43%+0.99%+34.83%+78.74% 454B
+5.14%+5.40%+33.75%+27.28% 341B
+1.85%+3.57%+37.09%+39.87% 297B
-0.11%+0.48%+18.87%+17.81% 262B
+0.25%-4.62%-27.66%-42.25% 215B
+1.49%-0.02%+20.14%+58.21% 201B
+0.40%-3.99%+15.23%+62.28% 162B
Average +1.28%+0.71%+21.19%+42.71% 361.83B
Weighted average by Cap. +1.74%+1.57%+35.44%+75.30%

Financials

2026 *2027 *
Net sales 3.46B 3.04B 2.83B 2.6B 4.87B 335B 4.96B 33.8B 13.18B 163B 12.99B 12.7B 567B 3.61B 3.18B 2.95B 2.71B 5.09B 350B 5.18B 35.29B 13.77B 171B 13.56B 13.27B 592B
Net income 405M 356M 331M 304M 570M 39.2B 581M 3.95B 1.54B 19.12B 1.52B 1.49B 66.33B 443M 389M 362M 333M 624M 42.86B 635M 4.32B 1.69B 20.91B 1.66B 1.63B 72.53B
Net Debt 1.47B 1.29B 1.2B 1.1B 2.07B 142B 2.11B 14.37B 5.6B 69.45B 5.52B 5.4B 241B 1.31B 1.15B 1.07B 987M 1.85B 127B 1.88B 12.83B 5B 62.01B 4.93B 4.82B 215B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. It supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). It supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. It supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.
Employees
9,400
Date Price Change Volume
26-07-23 GBX 1,553.00 -1.02% 1,123,404
26-07-22 GBX 1,569.00 +1.88% 2,031,610
26-07-21 GBX 1,540.00 0.00% 1,565,686
26-07-20 GBX 1,540.00 -1.35% 699,290
26-07-17 GBX 1,561.00 +0.64% 1,494,149
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.67USD
Average target price
24.84USD
Spread / Average Target
+20.19%

Quarterly revenue - Rate of surprise